Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;19(1):9.
doi: 10.1007/s11906-017-0698-1.

Multidisciplinary Approach in the Treatment of Resistant Hypertension

Affiliations
Review

Multidisciplinary Approach in the Treatment of Resistant Hypertension

S A Potthoff et al. Curr Hypertens Rep. 2017 Jan.

Abstract

With its high prevalence and the eminent number of undetected or poorly controlled patients, the management of arterial hypertension is still a challenging task. Uncontrolled blood pressure is the major adjustable risk factor for cardiovascular end organ damage for coronary heart disease, heart failure, stroke, and renal disease. Patients with resistant hypertension often need a multidisciplinary approach in order to control their blood pressure sustainably. In cooperation with hypertension specialists, the underlying cause for therapy resistance should be evaluated. Pseudohypertension, white coat hypertension, and non-adherence need to be addressed. The medication can often be optimized and simplified. Reducing the number of pills per day can enhance the drug-adherence remarkably. The multidisciplinary evaluation of secondary causes of hypertension includes an endocrinological work-up, ruling out relevant sleeping disorders, and renal diagnostics. If there are no causative treatments possible and pharmacological and non-pharmacological measurements are not sufficient to control the blood pressure, one has to consider multidisciplinary approaches bringing nurses, pharmacists, dieticians, physiotherapists, social workers, psychologists, and community health workers onboard. Utilizing various strategies might improve medication management, patient follow-up, adherence, and self-management. Interventional therapy such as renal renervation, baroreflex activation therapy, or carotid body modulation is the final option that can be discussed with interventional active colleagues. However, large randomized controlled trials proving a benefit of these interventional therapies are still missing. The use of these still experimental approaches should be restricted to randomized controlled trials accordingly.

Keywords: Adherence to therapy; Interventional therapy; Resistant hypertension; Secondary hypertension.

PubMed Disclaimer

Similar articles

Cited by

  • Development and implementation of blood pressure screening and referral guidelines for German community pharmacists.
    Schulz M, Griese-Mammen N, Schumacher PM, Strauch D, Freudewald L, Said A, Tsuyuki RT, Laufs U, Kintscher U, Böhm M, Mahfoud F. Schulz M, et al. J Clin Hypertens (Greenwich). 2020 Oct;22(10):1807-1816. doi: 10.1111/jch.14020. Epub 2020 Aug 30. J Clin Hypertens (Greenwich). 2020. PMID: 32864864 Free PMC article.
  • Brazilian Guidelines of Hypertension - 2020.
    Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa ADM, Machado CA, Poli-de-Figueiredo CE, Amodeo C, Mion Júnior D, Barbosa ECD, Nobre F, Guimarães ICB, Vilela-Martin JF, Yugar-Toledo JC, Magalhães MEC, Neves MFT, Jardim PCBV, Miranda RD, Póvoa RMDS, Fuchs SC, Alessi A, Lucena AJG, Avezum A, Sousa ALL, Pio-Abreu A, Sposito AC, Pierin AMG, Paiva AMG, Spinelli ACS, Nogueira ADR, Dinamarco N, Eibel B, Forjaz CLM, Zanini CRO, Souza CB, Souza DDSM, Nilson EAF, Costa EFA, Freitas EV, Duarte EDR, Muxfeldt ES, Lima Júnior E, Campana EMG, Cesarino EJ, Marques F, Argenta F, Consolim-Colombo FM, Baptista FS, Almeida FA, Borelli FAO, Fuchs FD, Plavnik FL, Salles GF, Feitosa GS, Silva GVD, Guerra GM, Moreno Júnior H, Finimundi HC, Back IC, Oliveira Filho JB, Gemelli JR, Mill JG, Ribeiro JM, Lotaif LAD, Costa LSD, Magalhães LBNC, Drager LF, Martin LC, Scala LCN, Almeida MQ, Gowdak MMG, Klein MRST, Malachias MVB, Kuschnir MCC, Pinheiro ME, Borba MHE, Moreira Filho O, Passarelli Júnior O, Coelho OR, Vitorino PVO, Ribeiro Junior RM, Esporcatte R, Franco R, Pedrosa R, Mulinari RA, Paula RB, Okawa RTP, Rosa RF, Amaral SLD, Ferreira-Filho SR, Kaiser SE, Jardim TSV, Guimarãe… See abstract for full author list ➔ Barroso WKS, et al. Arq Bras Cardiol. 2021 Mar;116(3):516-658. doi: 10.36660/abc.20201238. Arq Bras Cardiol. 2021. PMID: 33909761 Free PMC article. English, Portuguese. No abstract available.
  • Comprehensive Care Models for Cardiometabolic Disease.
    Reiter-Brennan C, Dzaye O, Davis D, Blaha M, Eckel RH. Reiter-Brennan C, et al. Curr Cardiol Rep. 2021 Feb 24;23(3):22. doi: 10.1007/s11886-021-01450-1. Curr Cardiol Rep. 2021. PMID: 33629209 Free PMC article. Review.
  • Effect of an emergency department education and empowerment intervention on uncontrolled hypertension in a predominately minority population: The AHEAD2 randomized clinical pilot trial.
    Prendergast H, Del Rios M, Durazo-Arvizu R, Escobar-Schulz S, Heinert S, Jackson M, Gimbar RP, Daviglus M, Lara B, Khosla S. Prendergast H, et al. J Am Coll Emerg Physicians Open. 2021 Mar 2;2(2):e12386. doi: 10.1002/emp2.12386. eCollection 2021 Apr. J Am Coll Emerg Physicians Open. 2021. PMID: 33718921 Free PMC article.

References

    1. J Vasc Surg. 2015 Jun;61(6):1613-23 - PubMed
    1. Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):79-80 - PubMed
    1. J Hypertens. 2013 Jul;31(7):1281-357 - PubMed
    1. J Am Soc Hypertens. 2016 Aug;10(8):656-70 - PubMed
    1. Ann Intern Med. 2006 Apr 4;144(7):485-95 - PubMed

Substances

LinkOut - more resources